Brian M. Strem, PhD
President & Chief Executive Officer
Brian was a co-founder and Director of Bayon Therapeutics, Inc., and Okogen, Inc. Prior to founding Okogen, Brian worked at Sound Pharmaceuticals, Allergan and Shire, where he was responsible for business development and corporate strategy in ophthalmology, otology and regenerative medicine. Brian began his career at Cytori Therapeutics with elevating roles within the commercial and R&D departments. Brian received his BS in Bioengineering from Cornell University and his PhD in Biomedical Engineering from UCLA.
Eric Daniels, MD, MBA
Chief Development Officer
Eric has nearly 20 years of operating experience in biotechnology and medtech companies. Prior to joining Kiora, he served as the CEO of OccuRx Pty Ltd as well as Co-founder and Director of Bayon Therapeutics, Inc., both focused on the development of next generation ophthalmic therapeutics. Eric is also a Co-Founder and Director of Okogen, Inc., a specialty ophthalmic biotechnology company. Eric previously served as part of the leadership teams at Puregraft LLC, Tensys Medical, and Cytori Therapeutics, Inc., serving in senior medical, R&D, and commercial roles. Eric holds an MBA from the Anderson School of Management at UCLA, where he also received his MD from the UCLA School of Medicine. Eric received his BS in Molecular Biology from the University of California, Berkeley.
Brenda Mann, PhD
Vice President of R&D
Brenda has extensive experience with hydrogels for wound healing and drug delivery applications. She is a co-founder of SentrX Animal Care, focused on veterinary biomaterials and manufacturer of the CMHA-S material. She is an adjunct associate professor in the Department of Bioengineering at the University of Utah. She was a founding faculty member of the Keck Graduate Institute of Applied Life Sciences, and now serves on its advisory council. Dr. Mann is also the Director of the Salt Lake Valley Science and Engineering Fair and a registered patent agent.
Stefan Sperl, PhD
Executive Vice President of CMC and Operations
Stefan acts as Executive Vice President CMC and Operations at Kiora. Previously, he was the co-founder and COO of Panoptes Pharma. Prior to this position he was global Project Manager at Nabriva Therapeutics AG, responsible for development of XENLETATM from early preclinical to clinical phase 2 programs. Before that he had various roles in R&D at Biovertis AG, Austria and Wilex AG, Germany. He has profound knowledge of drug development and is an inventor on numerous patents. Dr. Stefan Sperl received his PhD in Medicinal Chemistry from the Max Planck Institute in Martinsried, Germany.
Angela Dentiste, MBA
Vice President of Clinical Affairs
Angela Dentiste has 30 years of pharmaceutical development experience, primarily in Project Management and Clinical Operations. She has previously held senior management positions in contract pharmaceutical companies (PPD, AAIPharma) as well as small pharmaceutical development companies (Endeavor Pharmaceuticals, Osmotica Pharmaceuticals). She received her MBA from the University of North Carolina at Wilmington. Prior to working in pharmaceuticals, she served in the United States Army in Military Intelligence.
Executive Vice President of Finance
Melissa Tosca is the Executive Vice President of Finance for Kiora Pharmaceuticals. She has 22 years of public accounting and finance experience, including 15 years at biotechnology and life science companies. Prior to joining Kiora, Melissa served as Executive Director of Finance and Corporate Treasurer for Neomorph, where she managed the company’s finance and accounting functions. Prior to Neomorph, Melissa served as Director of Finance and Accounting at Omniome, where she built the accounting and finance infrastructure and managed the company’s financial operations. Prior to Omniome, she spent 9 years at Caris Life Sciences, serving in various leadership roles including Director of Finance and Accounting, Director of Financial Planning and Analysis and Senior Director of Sales Operations. Melissa began her professional career in public accounting at Clifton Gunderson and later Ernst and Young as an Audit Manager. Melissa is a Certified Public Accountant and holds a B.S. in Accounting from the University of Arizona.